About the journal
Biomarkers in Cancer is an open-access journal published by SAGE Publishing in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1179-299X
- Country
- United Kingdom
- Access
- Open access
- Official website
- http://insights.sagepub.com/journal-biomarkers-in-cancer-j154
Index listings
- PUBMED · 2010-02-18
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2019
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
145
Last recorded publication year
2019
h-index
34
i10-index
70
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2021
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Epigenetics and DNA Methylation
- MicroRNA in disease regulation
Show all subjects (50)
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Epigenetics and DNA Methylation
- Cancer Genomics and Diagnostics
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Gene expression and cancer classification
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Monoclonal and Polyclonal Antibodies Research
- Colorectal Cancer Treatments and Studies
- Gene expression and cancer classification
- Monoclonal and Polyclonal Antibodies Research
- Advanced Proteomics Techniques and Applications
- Advanced Biosensing Techniques and Applications
- Advanced Biosensing Techniques and Applications
- Advanced Proteomics Techniques and Applications
- Ovarian cancer diagnosis and treatment
- Peptidase Inhibition and Analysis
- Ovarian cancer diagnosis and treatment
- Peptidase Inhibition and Analysis
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Radiomics and Machine Learning in Medical Imaging
- Glycosylation and Glycoproteins Research
- RNA Research and Splicing
- Protease and Inhibitor Mechanisms
- Immunotherapy and Immune Responses
- Glioma Diagnosis and Treatment
- Cell Adhesion Molecules Research
- Radiomics and Machine Learning in Medical Imaging
- Gastric Cancer Management and Outcomes
- Cancer Research and Treatments
- Protease and Inhibitor Mechanisms
- RNA Research and Splicing
- Glycosylation and Glycoproteins Research
- Immunotherapy and Immune Responses
- Cell Adhesion Molecules Research
- Gastric Cancer Management and Outcomes
- Glioma Diagnosis and Treatment
- Cancer Research and Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ